Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    AZD6765 | Phase 2
Show Display Options
Rank Status Study
1 Completed AZD6765 Severe Major Depressive Disorder (MDD) IV
Condition: Major Depressive Disorder
Interventions: Drug: AZD6765;   Drug: Placebo
2 Completed
Has Results
This is a Study to Determine the Antidepressant Effects of AZD6765
Condition: Treatment Resistant Major Depressive Disorder
Interventions: Drug: AZD6765;   Drug: Placebo to AZD6765
3 Completed A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: AZD6765 iv;   Drug: Placebo
4 Completed AZD6765 for Treatment Resistant Depression
Condition: Depression
Intervention: Drug: AZD6765

Indicates status has not been verified in more than two years